Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Ocumetics Technology Corp V.OTC

Alternate Symbol(s):  OTCFF

Healthcare Medical Instruments & Supplies
Ocumetics Technology Corp. is a Canada-based research and product development company. The Company specializes in adaptive lens designs. The Company is focused on developing intraocular lens for people over 45 years of age. It is in the preclinical study stage of a technology for the ophthalmic industry. The Bionic Lens, which is an expandable intraocular lens that fits within the natural lens... see more

Recent & Breaking News (TSXV:OTC)

Ocumetics Technology Corp (OTC) To Be Featured on Radius Research's Pitch, Deep Dive and Q&A Webinar (Feb 29, 2024)

TheNewsWire February 29, 2024

Ocumetics Announces Completion of Unit Private Placement

TheNewsWire January 17, 2024

Ocumetics Announces Extension of Private Placement

TheNewsWire December 21, 2023

Ocumetics Announces December 20, 2023 Webinar regarding Successful Completion of Animal Study

TheNewsWire December 15, 2023

Ocumetics Technology completes animal study

Jocelyn Aspa December 7, 2023

Ocumetics Announces Successful Completion of Animal Study Q1 2024 First in Human Study Planned

TheNewsWire December 7, 2023

Ocumetics Announces Private Placement

TheNewsWire November 15, 2023

Ocumetics notches milestone with vision correction technology

Jocelyn Aspa September 18, 2023

Ocumetics Continues to Meet Significant Development Milestones; Lens Design Optimized for Upcoming First in Human Study

TheNewsWire September 18, 2023

Ocumetics Welcomes Dr. Doyle Stulting and Dr. Bart McRoberts to Board of Directors

TheNewsWire September 1, 2023

Ocumetics Announces Completion of Unit Private Placement

TheNewsWire August 15, 2023

Ocumetics Announces Completion of First Tranche of Unit Private Placement

TheNewsWire July 25, 2023

Ocumetics Announces Private Placement

TheNewsWire June 22, 2023

Ocumetics Announces Commencement of Biocompatibility and Animal Studies for Updated Lens Design

TheNewsWire June 20, 2023

Ocumetics Announces Appointment of President and CEO

TheNewsWire June 12, 2023

Ocumetics Announces Issuance of Shares

TheNewsWire June 2, 2023

Ocumetics Announces Corporate Changes

TheNewsWire April 24, 2023

Ocumetics Announces Design Lockdown to Enter Further Development Stages

TheNewsWire April 19, 2023

Ocumetics Announces Advertising Campaign with Investing News Network

TheNewsWire March 3, 2023

Ocumetics Announces Successful Completion of Animal Studies

TheNewsWire February 13, 2023